Tapewire

Nasdaq · USD

KNSA

Kiniksa Pharmaceuticals International, plc

Export transactions ↓
Tapewire entity
1954
SEC CIK
0001730430
Parsed reports
378

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202503
Jan 202601
Feb 202607
Mar 202605
Apr 2026012
May 202603
Jun 202600
Jul 202601
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2024 Filed Apr 3, 2024 21:25 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Tax withholdingClass A Common Share 514 $19.70 $10,125.80
Disclosure

SEC source: 0001415889-24-010091 · form4-04032024_090446.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,868

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:25 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Common Share 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010091 · form4-04032024_090446.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:23 UTC
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,773 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010088 · form4-04032024_090445.xml · derivative · entry 3

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,318

Underlying: Class A Common Share · 1,773 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:23 UTC
Tessari EbenCHIEF OPERATING OFFICER
Tax withholdingClass A Common Share 521 $19.70 $10,263.70
Disclosure

SEC source: 0001415889-24-010088 · form4-04032024_090445.xml · nonDerivative · entry 2

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,099

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:23 UTC
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Common Share 1,773 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010088 · form4-04032024_090445.xml · nonDerivative · entry 1

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:22 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionRestricted Share Unit · Derivative 6,482 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010086 · form4-04032024_090440.xml · derivative · entry 4

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,443

Underlying: Class A Common Share · 6,482 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:22 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Tax withholdingClass A Common Share 1,903 $19.70 $37,489.10
Disclosure

SEC source: 0001415889-24-010086 · form4-04032024_090440.xml · nonDerivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,095

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:22 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionClass A Common Share 6,482 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010086 · form4-04032024_090440.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:21 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,558 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010084 · form4-04032024_090431.xml · derivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,672

Underlying: Class A Common Share · 2,558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:21 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Tax withholdingClass A Common Share 1,084 $19.70 $21,354.80
Disclosure

SEC source: 0001415889-24-010084 · form4-04032024_090431.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,062

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:21 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 2,558 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010084 · form4-04032024_090431.xml · nonDerivative · entry 1

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:20 UTC
Moat RossCHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,612 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010079 · form4-04032024_090405.xml · derivative · entry 3

Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,833

Underlying: Class A Common Share · 1,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:20 UTC
Moat RossCHIEF COMMERCIAL OFFICER
Tax withholdingClass A Common Share 880 $19.70 $17,336.00
Disclosure

SEC source: 0001415889-24-010079 · form4-04032024_090405.xml · nonDerivative · entry 2

Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,152

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:20 UTC
Moat RossCHIEF COMMERCIAL OFFICER
Exercise / conversionClass A Common Share 1,612 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010079 · form4-04032024_090405.xml · nonDerivative · entry 1

Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:18 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,624 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010077 · form4-04032024_090447.xml · derivative · entry 3

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,872

Underlying: Class A Common Share · 1,624 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:18 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Tax withholdingClass A Common Share 477 $19.70 $9,396.90
Disclosure

SEC source: 0001415889-24-010077 · form4-04032024_090447.xml · nonDerivative · entry 2

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,039

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:18 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Common Share 1,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-010077 · form4-04032024_090447.xml · nonDerivative · entry 1

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 23:05 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
SaleClass A Common Share 65,012 $21.02 $1,366,552.24
Disclosure

SEC source: 0001415889-24-007569 · form4-03112024_110346.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.145. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 06, 2024 Filed Mar 6, 2024 22:37 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
SaleClass A Common Share 5,582 $21.00 $117,222.00
Disclosure

SEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 3

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 65,012

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
March 04, 2024 Filed Mar 6, 2024 22:37 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
SaleClass A Common Share 3,336 $22.00 $73,392.00
Disclosure

SEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 70,594

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
March 04, 2024 Filed Mar 6, 2024 22:37 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
SaleClass A Common Share 9,406 $21.31 $200,441.86
Disclosure

SEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 73,930

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.785. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionShare Option · Derivative 4,014 $0.00 Strike: $13.88 $0.00
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 9

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Share · 4,014 shares

Expires 2028-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F5 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionShare Option · Derivative 5,645 $0.00 Strike: $8.83 $0.00
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 8

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 229

Underlying: Class A Common Share · 5,645 shares

Expires 2029-09-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F5 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
SaleClass A Common Share 9,659 $21.45 $207,185.55
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 6

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,588

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.45 to $21.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 4,014 $13.88 $55,714.32
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 5

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,247

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 5,645 $8.83 $49,845.35
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 4

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:34 UTC
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionShare Option · Derivative 656 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0001415889-24-006702 · form4-03052024_090322.xml · derivative · entry 3

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,017

Underlying: Class A Common Share · 656 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:34 UTC
Tessari EbenCHIEF OPERATING OFFICER
SaleClass A Common Share 1,189 $22.03 $26,193.67
Disclosure

SEC source: 0001415889-24-006702 · form4-03052024_090322.xml · nonDerivative · entry 2

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,847

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.03 and $22.055. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:34 UTC
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Common Share 656 $1.59 $1,043.04
Disclosure

SEC source: 0001415889-24-006702 · form4-03052024_090322.xml · nonDerivative · entry 1

Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:31 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionShare Option · Derivative 18,844 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001415889-24-006674 · form4-03052024_090325.xml · derivative · entry 3

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,217

Underlying: Class A Common Shares · 18,844 shares

Expires 2026-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:31 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Common Share 18,844 $21.77 $410,233.88
Disclosure

SEC source: 0001415889-24-006674 · form4-03052024_090325.xml · nonDerivative · entry 2

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,892

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.21 to $22.07. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:31 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Common Share 18,844 $1.86 $35,049.84
Disclosure

SEC source: 0001415889-24-006674 · form4-03052024_090325.xml · nonDerivative · entry 1

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,736

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionShare Option · Derivative 5,126 $0.00 Strike: $8.83 $0.00
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 7

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,874

Underlying: Class A Common Share · 5,126 shares

Expires 2029-09-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F5 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
SaleClass A Common Share 5,126 $21.79 $111,695.54
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,588

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.56 to $21.90. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 5,126 $8.83 $45,262.58
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionShare Option · Derivative 10,156 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001415889-24-005883 · form4-02292024_090213.xml · derivative · entry 3

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,061

Underlying: Class A Common Shares · 10,156 shares

Expires 2026-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Common Share 10,156 $21.03 $213,580.68
Disclosure

SEC source: 0001415889-24-005883 · form4-02292024_090213.xml · nonDerivative · entry 2

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,892

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.00 to $21.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Common Share 10,156 $1.86 $18,890.16
Disclosure

SEC source: 0001415889-24-005883 · form4-02292024_090213.xml · nonDerivative · entry 1

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,048

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
January 15, 2024 Filed Mar 1, 2024 23:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
GrantClass A Common Share 583 $12.35 $7,200.05
Disclosure

SEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 1

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,588

F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2023 to January 15, 2024. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:30 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 12,000 $0.00 Strike: $8.83 $0.00
Disclosure

SEC source: 0001415889-24-000609 · form4-01042024_040113.xml · derivative · entry 3

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Share · 12,000 shares

Expires 2029-09-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:30 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
SaleClass A Common Share 12,000 $20.00 $240,000.00
Disclosure

SEC source: 0001415889-24-000609 · form4-01042024_040113.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,632

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:30 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Common Share 12,000 $8.83 $105,960.00
Disclosure

SEC source: 0001415889-24-000609 · form4-01042024_040113.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:30 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionShare Option · Derivative 16,670 $0.00 Strike: $13.88 $0.00
Disclosure

SEC source: 0001415889-24-000608 · form4-01042024_040110.xml · derivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,014

Underlying: Class A Common Share · 16,670 shares

Expires 2028-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:30 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
SaleClass A Common Share 16,670 $19.17 $319,563.90
Disclosure

SEC source: 0001415889-24-000608 · form4-01042024_040110.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,005

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $19.13 to $19.43. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:30 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 16,670 $13.88 $231,379.60
Disclosure

SEC source: 0001415889-24-000608 · form4-01042024_040110.xml · nonDerivative · entry 1

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 21:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionShare Option · Derivative 9,316 $0.00 Strike: $13.88 $0.00
Disclosure

SEC source: 0001415889-23-016827 · form4-12212023_091222.xml · derivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,684

Underlying: Class A Common Share · 9,316 shares

Expires 2028-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 21:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
SaleClass A Common Share 9,316 $19.13 $178,215.08
Disclosure

SEC source: 0001415889-23-016827 · form4-12212023_091222.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,005

Read SEC document
December 19, 2023 Filed Dec 21, 2023 21:26 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Common Share 9,316 $13.88 $129,306.08
Disclosure

SEC source: 0001415889-23-016827 · form4-12212023_091222.xml · nonDerivative · entry 1

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

Read SEC document
December 07, 2023 Filed Dec 11, 2023 21:20 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionShare Option · Derivative 28,600 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001415889-23-016183 · form4-12112023_041201.xml · derivative · entry 6

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,217

Underlying: Class A Common Shares · 28,600 shares

Expires 2026-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F6 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
December 07, 2023 Filed Dec 11, 2023 21:20 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Common Share 1,501 $17.81 $26,732.81
Disclosure

SEC source: 0001415889-23-016183 · form4-12112023_041201.xml · nonDerivative · entry 5

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,892

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.

F5 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.80 to $17.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.